LMEDICATION: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LMEDICATION
Largest movements
- Receivables within one year -€24,330
down €24,330 (-20.1%), from €120,820 to €96,490
of which Other amounts receivable: -€40,000
- Cash +€6,800
up €6,800 (+63.7%), from €10,667 to €17,467
mainly Debts after one year (+€76,967) and Net result for the year (+€39,690)
- Debts after one year +€76,967
up €76,967 (+87.2%), from €88,216 to €165,184
- Other debts -€53,000
down €53,000 (-99.3%), from €53,373 to €373
- Profit (loss) carried forward -€30,310
down €30,310 (-42.0%), from €72,245 to €41,934
- Tax, wage and social debts -€12,400
down €12,400 (-70.2%), from €17,665 to €5,265
- Gross operating margin +€7,687
up €7,687 (+15.5%), from €49,662 to €57,349
- Taxes +€2,497
up €2,497 (+21.8%), from €11,443 to €13,940
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €246,425 | €228,494 | -€17,931 | -7.3% |
| Fixed assets | 21/28 | €113,691 | €113,691 | = | 0.0% |
| Financial fixed assets | 28 | €113,691 | €113,691 | = | 0.0% |
| Current assets | 29/58 | €132,734 | €114,803 | -€17,931 | -13.5% |
| Amounts receivable within one year | 40/41 | €120,820 | €96,490 | -€24,330 | -20.1% |
| Trade receivables | 40 | €50,820 | €66,490 | +€15,670 | +30.8% |
| Other amounts receivable | 41 | €70,000 | €30,000 | -€40,000 | -57.1% |
| Cash at bank and in hand | 54/58 | €10,667 | €17,467 | +€6,800 | +63.7% |
| Deferred charges and accrued income | 490/1 | €1,246 | €846 | -€400 | -32.1% |
| Total equity and liabilities | 10/49 | €246,425 | €228,494 | -€17,931 | -7.3% |
| Equity | 10/15 | €75,245 | €44,934 | -€30,310 | -40.3% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €72,245 | €41,934 | -€30,310 | -42.0% |
| Amounts payable | 17/49 | €171,180 | €183,560 | +€12,380 | +7.2% |
| Amounts payable after more than one year | 17 | €88,216 | €165,184 | +€76,967 | +87.2% |
| Financial debts | 170/4 | €88,216 | €165,184 | +€76,967 | +87.2% |
| Amounts payable within one year | 42/48 | €82,658 | €18,102 | -€64,556 | -78.1% |
| Current portion of amounts payable after more than one year | 42 | €10,980 | €11,393 | +€413 | +3.8% |
| Trade debts | 44 | €641 | €1,071 | +€430 | +67.1% |
| Suppliers | 440/4 | €641 | €1,071 | +€430 | +67.1% |
| Taxes, remuneration and social security | 45 | €17,665 | €5,265 | -€12,400 | -70.2% |
| Taxes | 450/3 | €17,665 | €5,265 | -€12,400 | -70.2% |
| Other amounts payable | 47/48 | €53,373 | €373 | -€53,000 | -99.3% |
| Accrued charges and deferred income | 492/3 | €306 | €275 | -€31 | -10.2% |
| Other operating charges | 640/8 | €112 | €149 | +€37 | +33.3% |
| Gross operating margin | 9900 | €49,662 | €57,349 | +€7,687 | +15.5% |
| Operating profit (loss) | 9901 | €49,551 | €57,201 | +€7,650 | +15.4% |
| Financial charges | 65/66B | €3,956 | €3,571 | -€385 | -9.7% |
| Recurring financial charges | 65 | €3,956 | €3,571 | -€385 | -9.7% |
| Profit (loss) for the period before taxes | 9903 | €45,595 | €53,630 | +€8,035 | +17.6% |
| Income taxes | 67/77 | €11,443 | €13,940 | +€2,497 | +21.8% |
| Profit (loss) for the period | 9904 | €34,152 | €39,690 | +€5,538 | +16.2% |
| Profit (loss) for the period to be appropriated | 9905 | €34,152 | €39,690 | +€5,538 | +16.2% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.